Oxybutynin Chloride Tablet
Product Images NDC 67296-2045

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 67296-2045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container5mg1000cc (5mg1000ct)

Label for Oxybutynin Chloride Tablets USP 5 mg oral tablets, showing the product name, strength, dosage form, package quantity of 1000 tablets, and Rx only status. The label includes dosing instructions for adults and pediatric patients, storage conditions, manufacturer and distributor information, and barcodes. The labeler is Leading Pharma.*

FDA Label Image

Container5mg100cc (5mg100ct)

Oxybutynin Chloride Tablets USP 5 mg oral tablets in a pack of 100, labeled by Redpharm Drug under the NDC 67296-2045. The label includes product name, strength, tablet depiction, dosing instructions, manufacturer information, and barcodes.*

FDA Label Image

Container5mg500cc (5mg500ct)

Label for Oxybutynin Chloride Tablets, USP 5 mg oral tablets. The label displays two round tablets imprinted with 'P' and '182'. It specifies a package of 500 tablets for prescription use, provided by Leading Pharma. The label includes dosing instructions, storage conditions, manufacturer and distributor information, as well as barcode details.*

FDA Label Image

Chem Structure (Chemstructure)

Chemical structure of oxybutynin chloride, depicting its molecular formula and arrangement including the aromatic ring, ester group, alkyne linker, and quaternary ammonium ion paired with chloride.*

FDA Label Image

Figure1 (Figure1)

A line graph showing mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours plotted against time (hours) for Oxybutynin 5 mg TID oral tablets. The graph includes error bars indicating variability and shows three peaks corresponding to dosing times.*

FDA Label Image

Figure2 (Figure2)

A line graph showing the mean plasma concentration of R-Oxybutynin (ng/mL) over time (hours). The graph depicts an initial increase in concentration peaking around 1 hour, then a gradual decline up to 12 hours, including standard deviation error bars at each time point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.